Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis

Abstract

Background: Older people often receive multiple medications for chronic conditions, which often result in polypharmacy (concomitant use of 5‒9 medicines) and hyperpolypharmacy (concomitant use of ≥10 medicines). A limited number of studies have been performed to evaluate the prevalence of polypharmacy, hyperpolypharmacy, and potentially inappropriate medication (PIM) use in older people of developing countries. The present study aimed to investigate regional variations in the prevalence of polypharmacy, hyperpolypharmacy, and PIM use in older people (60 + years) in India.Methods: Studies were identified using Medline/PubMed, Scopus, and Google Scholar databases published from inception (2002) to September 31, 2020. Out of the total 1890 articles, 27 were included in the study.Results: Overall, the pooled prevalence of polypharmacy was 49% (95% confidence interval: 42–56; p < 0.01), hyperpolypharmacy was 31% (21–40; p < 0.01), and PIM use was 28% (24–32; p < 0.01) among older Indian adults. Polypharmacy was more prevalent in North-east India (65%, 50–79), whereas hyperpolypharmacy was prevalent in south India (33%, 17–48). Region-wize estimates for the pooled prevalence of PIM use in India were as follows: 23% (21–25) in East, 33% in West (24–42), 17.8% in North (11–23), and 32% (26–38) in South India. The prevalence of PIM use in adults aged ≥70°years was 35% (28–42), in those taking more medications (≥5.5/day) was 27% (22–31), and in adults using a high number of PIMs (≥3) was 29% (22–36). Subgroup analysis showed that cross-sectional studies had a higher pooled prevalence of polypharmacy 55% (44–65) than cohorts 45% (37–54). Hyperpolypharmacy in inpatient care settings was 37% (26–47), whereas PIM use was higher in private hospitals 31% (24–38) than government hospitals 25% (19–31).Conclusion: Polypharmacy and hyperpolypharmacy are widely prevalent in India. About 28% of older Indian adults are affected by PIM use. Thus, appropriate steps are needed to promote rational geriatric prescribing in India.Systematic Review Registration: https://clinicaltrials.gov, identifier [CRD42019141037].

Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis

“…Furthermore, polypharmacy is more frequently observed in inpatients (73%) than outpatients (23%). This is different from another study about the prevalence of polypharmacy observed in two categories ( Bhagavathula et al, 2021 ).…”

A chemical perspective on the clinical use of platinum-based anticancer drugs

“…A patient who takes between 5 and 9 different drugs per day is said to have polypharmacy and a patient who takes 10 or more drugs per day is said to have hyper-polypharmacy. 83,84…”

“…A patient who takes between 5 and 9 different drugs per day is said to have polypharmacy and a patient who takes 10 or more drugs per day is said to have hyper-polypharmacy. 83,84 This is an issue for chemotherapy, and especially for platinum-based chemotherapy, given that 46% of hospital chemotherapy patients are administered a platinum, 8 and because 35% of elderly (70+ years of age) cancer patients have polypharmacy. 85 Because of this, 30-75% of these patients are likely to experience changes in efficacy and side effects due to drug-drug interactions with their platinum agents.…”

Estado nutricional de los adultos mayores de Antioquia y su relación con enfermedades y consumo de medicamentos

“…Cabe aclarar que el término polifarmacia tiene más de 24 definiciones en la literatura médica y que se considera como una prescripción extraordinaria, es decir, cuando una persona toma más medicamentos de los necesarios o tiene una prescripción inadecuada, con puntos de corte que varían desde 4 hasta 10 o más; cuando se sobrepasan los nueve medicamentos algunos autores lo denominan hiperpolifarmacia (21,22). Para este estudio se consideró polifarmacia el consumo de 4 medicamentos o más, lo que podría llevar a limitaciones en la comparación con investigaciones que utilizaron otros puntos para definirla.…”